Tech Company Financing Transactions

Peloton Therapeutics Funding Round

Peloton Therapeutics closed a $150 million Series E funding round on 2/21/2019. Backers included RA Capital, BVF Partners and Curative Ventures.

Transaction Overview

Announced On
Transaction Type
Venture Equity
Series E
Proceeds Purpose
Proceeds from this financing will be used to advance Peloton's research and development pipeline, including our lead drug candidate, PT2977, a potent and selective oral HIF-2a inhibitor.

Company Information

Company Status
Private & Independent
Mailing Address
2330 Inwood Rd. 226
Dallas, TX 75235
Email Address
Working in close collaboration with scientists at UT Southwestern, Peloton is advancing a promising discovery and development pipeline, comprised of several small molecule-based programs, each with a distinct target and mechanism of action.
Peloton Therapeutics LinkedIn Company Profile
Social Media
Peloton Therapeutics Company Twitter Account
Company News
Peloton Therapeutics News
Peloton Therapeutics on Facebook
Peloton Therapeutics on YouTube

Management Team

Email & Social
Chief Executive Officer
John Josey
  John Josey LinkedIn Profile  John Josey Twitter Account  John Josey News  John Josey on Facebook
Chief Financial Officer
Alan Musso
  Alan Musso LinkedIn Profile  Alan Musso Twitter Account  Alan Musso News  Alan Musso on Facebook
Chief Medical Officer
Mohammad Hirmand
  Mohammad Hirmand LinkedIn Profile  Mohammad Hirmand Twitter Account  Mohammad Hirmand News  Mohammad Hirmand on Facebook
Chief Scientific Officer
Eli Wallace
  Eli Wallace LinkedIn Profile  Eli Wallace Twitter Account  Eli Wallace News  Eli Wallace on Facebook
Vice President
James Rizzi
  James Rizzi LinkedIn Profile  James Rizzi Twitter Account  James Rizzi News  James Rizzi on Facebook
Vice President
Naseem Zojwalla
  Naseem Zojwalla LinkedIn Profile  Naseem Zojwalla Twitter Account  Naseem Zojwalla News  Naseem Zojwalla on Facebook
VP - General Counsel
John Moore
  John Moore LinkedIn Profile  John Moore Twitter Account  John Moore News  John Moore on Facebook
VP - Operations
Michael Bakes
  Michael Bakes LinkedIn Profile  Michael Bakes Twitter Account  Michael Bakes News  Michael Bakes on Facebook
VP - Regulatory Affairs
Cheryl Madsen
  Cheryl Madsen LinkedIn Profile  Cheryl Madsen Twitter Account  Cheryl Madsen News  Cheryl Madsen on Facebook



Browse more venture capital transactions:

Prev: 2/21/2019: Clutter venture capital transaction
Next: 2/21/2019: ThousandEyes venture capital transaction


Share this article


News on VC Transactions

We document all VC transactions involving tech companies. VC investment data records on this site are sourced from news reports and company announcements. The data is sourced from, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary